bromopyruvate has been researched along with Thyroid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, A; Barletta, JA; Kijewski, MF; Lorch, JH; Marshall, JA; Nehs, MA; Zhao, B | 1 |
1 other study(ies) available for bromopyruvate and Thyroid Neoplasms
| Article | Year |
|---|---|
Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Diet, Ketogenic; Female; Humans; Mice; Pyruvates; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Burden; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays | 2022 |